Guggenheim Community Impact aimed to honor and strengthen the firm’s principles of stewardship and collaboration by enabling employees to step forward and give back to local communities where they work and live.
Guggenheim’s three-week campaign brought together more than 900 volunteers who participated in a wide range of activities from revitalizing public parks to facilitating summer camp programs for children. Guggenheim CSR organized more than 40 volunteer events with 32 non-profit organizations contributing more than 2,500 hours of service. This year saw a 33 percent increase in service hours and a 36 percent increase in employee participation.
“This year’s Guggenheim Community Impact exemplified the strengths of Guggenheim’s culture – our employees worked together to help those in need, and committed their time, talents and efforts to make a difference in our communities,” said Head of CSR Lauren Coape-Arnold. “Thank you to all of our volunteers and non-profit partners for working together to drive social change.”
Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that it completed its previously announced acquisition of Millstein & Co., a leading advisor to companies, investors, governments and other stakeholders facing complex financial issues, including providing advice on restructuring, mergers and acquisitions and liability management transactions.
Read More
Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Matthew Brogdon has joined the firm as a Senior Managing Director in the firm’s Houston-based Oil and Gas investment banking group.
Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Yatin Suneja will join the firm in November as a Managing Director, continuing the firm’s planned expansion of the Healthcare Research team. Mr. Suneja will focus on the coverage of Biotechnology companies in close collaboration with our growing therapeutics team.
You are now leaving this website.Guggenheim assumes no responsibility of the content or its accuracy.
© 2018 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.